KBR’s Foreign Contractors at Guantanamo Spared Controversial Anti-Malarial Drug Given to Detainees
The Defense Department has claimed it took the unprecedented step of forcing all "war on terror" detainees sent to Guantanamo in 2002 to take a high dosage of a controversial anti-malarial drug known to have severe side effects because the government was concerned the disease could be reintroduced into Cuba by detainees arriving from malaria-endemic countries Afghanistan and Pakistan.
But hundreds of contractors who were hired by Kellogg Brown & Root (KBR)
